Liraglutide 3 mg (Saxenda) , also a GLP-1 receptor agonist, is recommended by NICE (TA664) for adults with a BMI of 35 kg/m or above (or 32.5 kg/m in certain ethnic groups) and prediabetes, within a specialist weight management service
Glatt S, Jemec GBE, Forman S, Sayed C, Schmieder G, Weisman J, et al
Your health goals Both oral and injectable Wegovy are approved for chronic weight management , but they differ in dosage and clinical trial data
The treatment also slows down how fast the food is digested, allowing you to feel full for a longer period of time
Some people might not be aware that this chronic health condition can significantly affect the quality of their blood components, including plasma
How effective are GLP-1 drugs in weight loss